Inogen(NASDAQ) INGN

Inogen, Inc. is a leading medical technology company specializing in portable oxygen concentrators (POCs) for patients with chronic respiratory conditions. By concentrating ambient air to deliver supplemental oxygen, Inogen’s products allow for increased mobility and independence, crucial for those in need of long-term oxygen therapy. The company operates globally, providing innovative respiratory solutions across various markets, with a dedicated commitment to enhancing patient quality of life.

Products and Services

Inogen One: Portable oxygen concentrators featuring the latest Intelligent Delivery Technology.

Inogen Rove: Lightweight systems designed for mobility and ease of use.

Simeox: An airway clearance device for treating bronchiectasis and other conditions.

Inogen At Home: A stationary oxygen concentrator for continuous oxygen delivery.

What Makes Inogen, Inc. Special

Inogen's innovative product design and robust direct-to-consumer sales model distinguish it within the portable oxygen concentrator market. This approach fosters stronger customer relationships, allowing for valuable feedback and continuous improvement. The company's commitment to customer-centric technology and comprehensive support services enhances mobility and independence for oxygen therapy users.

Five Things You Need to Know

Inogen's POCs improve patient mobility, reducing reliance on stationary devices and oxygen tanks.

The company pioneered the direct-to-consumer sales model in the oxygen therapy sector.

Recent acquisition of Physio-Assist expands Inogen's reach into the bronchiectasis market.

The executive team prioritizes operational excellence and strategic market expansion.

Inogen invests heavily in R&D to lead the development of next-generation respiratory solutions.